These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 25623736)

  • 21. Cognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised, observer-blinded multi-centre clinical trial.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Forchhammer HB; Melau M; Gluud C; Nordentoft M
    Trials; 2011 Feb; 12():35. PubMed ID: 21306612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Soyata AZ; Akışık S; İnhanlı D; Noyan H; Üçok A
    Psychiatry Res; 2018 Mar; 261():332-337. PubMed ID: 29334657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial.
    Jespersen AE; Lumbye A; Vinberg M; Glenthøj L; Nordentoft M; Wæhrens EE; Knudsen GM; Makransky G; Miskowiak KW
    Trials; 2024 Jan; 25(1):82. PubMed ID: 38268043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk.
    Kim HS; Shin NY; Jang JH; Kim E; Shim G; Park HY; Hong KS; Kwon JS
    Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
    Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
    Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; Akay A; İnal N; Akdede BB
    Schizophr Res; 2024 Apr; 266():58-65. PubMed ID: 38368706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between duration of untreated psychosis and neurocognition and social cognition in first-episode psychosis.
    On ZX; Cotton S; Farhall J; Killackey E; Allott K
    Schizophr Res; 2016 Oct; 176(2-3):529-532. PubMed ID: 27344985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.
    Reininghaus U; Klippel A; Steinhart H; Vaessen T; van Nierop M; Viechtbauer W; Batink T; Kasanova Z; van Aubel E; van Winkel R; Marcelis M; van Amelsvoort T; van der Gaag M; de Haan L; Myin-Germeys I
    Trials; 2019 Dec; 20(1):769. PubMed ID: 31878966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis.
    Glenthøj LB; Jepsen JR; Hjorthøj C; Bak N; Kristensen TD; Wenneberg C; Krakauer K; Nordentoft M; Fagerlund B
    Acta Psychiatr Scand; 2017 Mar; 135(3):250-258. PubMed ID: 27988937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
    Mallawaarachchi SR; Amminger GP; Farhall J; Bolt LK; Nelson B; Yuen HP; McGorry PD; Markulev C; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2020 Apr; 218():48-54. PubMed ID: 32171637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study.
    Pelizza L; Poletti M; Azzali S; Garlassi S; Scazza I; Paterlini F; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2020 Dec; 29(12):1645-1657. PubMed ID: 32016572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
    Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
    Trials; 2017 May; 18(1):233. PubMed ID: 28545578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis.
    Kim KR; Song YY; Park JY; Lee EH; Lee M; Lee SY; Kang JI; Lee E; Yoo SW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2013 Aug; 47(8):762-71. PubMed ID: 23661784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.